EuSEM logo AAEM logo
Abstracts/Posters | Social Events | Congress Satellite Courses | Program | Registration | Hotel Information | Travel Information
Co-Organizing Societies & Foundations | Sponsoring Societies & Organizations | Hosting Institutions | Committees
Presidents & Keynote Speakers | Presidents' Message | Speakers | Exhibitor Information | Supporters | ACCME Information | EM Congress Home
Photo Gallery | MEMCIV-2007, Sorrento, Italy | MEMCII-2005, Nice, France | MEMCI-2001, Stresa, Italy


American Academy of Emergency Medicine
Disclosure Policy

AAEM endorses the guidelines for accredited continuing medical education programs as set forth in the ACCME's "Standards for Commercial Support of Continuing Medical Education" and adheres to them in the conduct of its educational activities. AAEM maintains control over the development of its educational programs and the selection of topics and presenters.

A full disclosure of proprietary interests is required of all presenters and faculty members and the presence of any such relationship will be reported to all program attendees. Even with disclosure, presentations should not promote use of a commercial product. AAEM is committed to the non-promotional advancement of knowledge and science in Emergency Medicine.

Session presenters and faculty members are required to disclose proprietary interests on the enclosed disclosure statement and at the time of their presentation. Failure to disclose proprietary interests on the statement or at the time of presentation will result in exclusion from future programs for up to five years.

Faculty members are encouraged to use generic rather than trade drug names in conjunction with AAEM educational activities. In addition, multiple drugs and/or therapies should be discussed whenever it is appropriate to do so. Any discussion of unlabeled uses of products regulated or still under investigation of the FDA must be disclosed as such to the audience.